Compare Personalis Inc. Common Stock (PSNL) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Personalis Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Personalis Inc. Common Stock trades at $16.14 (market cap $1.70B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.76B). The key difference: Personalis Inc. Common Stock and Vir Biotechnology Inc. Common Stock are close in size by market cap, and Personalis Inc. Common Stock is more actively traded (3,262,398 versus 2,764,948). Which is the better fit depends on your goals — on Pluang, investors hold Personalis Inc. Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| PSNL | VIR | |
|---|---|---|
Market Cap | $1.70B | $1.76B |
Volume | 3,262,398 | 2,764,948 |
Sector | Health | Health |
52-Week High | $18.38 | $11.78 |
52-Week Low | $5.04 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.52B | $1.32B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Personalis Inc. Common Stock
Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
